Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norisato Mitsutake

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Anticancer Research|January 30, 2008
Overexpression of wild-type THRbeta1 suppresses the growth and invasiveness of human papillary thyroid cancer cellsIlya Sedliarou, Michiko Matsuse, Vladimir Saenko, et al.
Endocrine Journal|October 25, 2008
Mutation analysis of RAP1 gene in papillary thyroid carcinomasMichiko Matsuse, Norisato Mitsutake, Tatiana Rogounovitch, et al.
Diagnostic Pathology|June 20, 2023
Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinomaMitsuyoshi Hirokawa, Michiko Matsuse, Norisato Mitsutake, et al.
Journal of Radiation Research|October 30, 2007
A novel role for thyroid hormone receptor beta in cellular radiosensitivityMichiko Matsuse, Vladimir Saenko, Ilya Sedliarou, et al.
Scientific Reports|February 3, 2017
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factorsMichiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
Journal of Dermatological Science|April 15, 2008
DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblastsSachio Makino, Norisato Mitsutake, Masahiro Nakashima, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the diseaseIñigo Landa, Ian Ganly, Timothy A Chan, et al.
Endocrine Journal|July 7, 2017
Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complexMitsuyoshi Hirokawa, Akira Miyauchi, Minoru Kihara, et al.
The Journal of Investigative Dermatology|February 24, 2012
miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblastsKazuya Kashiyama, Norisato Mitsutake, Michiko Matsuse, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cellsAlexei Podtcheko, Akira Ohtsuru, Satoshi Tsuda, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Anticancer Research|January 30, 2008
Overexpression of wild-type THRbeta1 suppresses the growth and invasiveness of human papillary thyroid cancer cellsIlya Sedliarou, Michiko Matsuse, Vladimir Saenko, et al.
Endocrine Journal|October 25, 2008
Mutation analysis of RAP1 gene in papillary thyroid carcinomasMichiko Matsuse, Norisato Mitsutake, Tatiana Rogounovitch, et al.
Diagnostic Pathology|June 20, 2023
Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinomaMitsuyoshi Hirokawa, Michiko Matsuse, Norisato Mitsutake, et al.
Journal of Radiation Research|October 30, 2007
A novel role for thyroid hormone receptor beta in cellular radiosensitivityMichiko Matsuse, Vladimir Saenko, Ilya Sedliarou, et al.
Scientific Reports|February 3, 2017
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factorsMichiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
Journal of Dermatological Science|April 15, 2008
DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblastsSachio Makino, Norisato Mitsutake, Masahiro Nakashima, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the diseaseIñigo Landa, Ian Ganly, Timothy A Chan, et al.
Endocrine Journal|July 7, 2017
Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complexMitsuyoshi Hirokawa, Akira Miyauchi, Minoru Kihara, et al.
The Journal of Investigative Dermatology|February 24, 2012
miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblastsKazuya Kashiyama, Norisato Mitsutake, Michiko Matsuse, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cellsAlexei Podtcheko, Akira Ohtsuru, Satoshi Tsuda, et al.
Pageof 11